Search

Search Results
Results 16321 - 16330 of 17228 for Active treatment
  • Shingrix
    Drug - 31 Mar 2026
    Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.
  • Quantifying pharmaceutical powder blends with Raman spectroscopy and chemometrics
    White Paper - 26 Mar 2026
    Chemometric Raman analysis enables fast, non-invasive quantification of APIs and excipients within pharmaceutical powder blends.
  • Raman spectroscopy for quantitative pharmaceutical analysis
    White Paper - 26 Mar 2026
    Explore how Raman spectroscopy supports quantitative pharmaceutical analysis by enabling accurate measurement of active ingredients.
  • Somac
    Drug - 26 Mar 2026
    Consumer Medicine Information (CMI) about Somac intended for persons living in Australia.
  • Norvir
    Drug - 23 Mar 2026
    Consumer Medicine Information (CMI) about Norvir intended for persons living in Australia.
  • Kaletra
    Drug - 19 Mar 2026
    Consumer Medicine Information (CMI) about Kaletra intended for persons living in Australia.
  • Vaxelis
    Drug - 4 Mar 2026
    Consumer Medicine Information (CMI) about Vaxelis intended for persons living in Australia.
  • Why the future of precision medicine depends on biomarker signature strategy
    White Paper - 26 Feb 2026
    Explore how strategic biomarker signatures are shaping the next era of precision medicine.
  • Ultra-low-power TMR switches for reliable CGM activation
    White Paper - 26 Feb 2026
    Ultra-low-power TMR switches enable reliable CGM activation by minimizing energy consumption while maintaining accurate, responsive device performance.
  • Nesina Met
    Drug - 23 Feb 2026
    Consumer Medicine Information (CMI) about Nesina Met intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback